Would you recommend PMRT in a patient with dermal invasion as the sole adverse feature after a skin sparing mastectomy for an early stage breast cancer?

Pathological dermis involvement in these early stage patients is function of location ( like retroareolar or superficial location) rather than aggressiveness of disease and thus outcome is more like early stage disease

In absence of other adverse factor I would favor observation